| Dr Laura Jane Koehn, MD | |
|
2100 N Green Acres Rd, Suite A, Fayetteville, AR 72703-2807 | |
| (479) 521-3363 | |
| (479) 521-4167 |
| Full Name | Dr Laura Jane Koehn |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology |
| Location | 2100 N Green Acres Rd, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124077078 | NPI | - | NPPES |
| 325026 | Other | AR | HEALTHLINK PROV # |
| 52963 | Other | AR | BCBS PROV # |
| 12198000000 | Other | AR | QUALCHOICE PROV # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | R2085 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Jane Koehn, MD 2100 N Green Acres Rd, Suite A, Fayetteville, AR 72703-2807 Ph: (479) 521-3363 | Dr Laura Jane Koehn, MD 2100 N Green Acres Rd, Suite A, Fayetteville, AR 72703-2807 Ph: (479) 521-3363 |
News Archive
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets, 10 mg, the generic version of Merck's Singulair Tablets.
A new evidence-based instrument to assess and classify peristomal skin lesions was launched at the 2010 Joint Conference of the Wound, Ostomy and Continence Nurses Society and World Council of Enterostomal Therapists. The instrument, known as the SACS Instrument, represents the first content-validated instrument to objectively assess and classify peristomal lesions by type and location in relation to an individual's stoma.
Covidien plc today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its Endo GIA Reinforced Reload with Tri-Staple technology.
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.
Adults with diabetes and multi-vessel coronary heart disease who underwent cardiac bypass surgery had better overall heart-related outcomes than those who underwent an artery-opening procedure to improve blood flow to the heart muscle, according to the results from an international study. The research was supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
› Verified 3 days ago
Dr. Martha Ann Hutson-fincher, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2100 N Green Acres Rd, Suite A, Fayetteville, AR 72703 Phone: 479-521-3363 Fax: 479-521-4167 |